661 related articles for article (PubMed ID: 25056883)
21. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide analyses of Zta binding to the Epstein-Barr virus genome reveals interactions in both early and late lytic cycles and an epigenetic switch leading to an altered binding profile.
Ramasubramanyan S; Kanhere A; Osborn K; Flower K; Jenner RG; Sinclair AJ
J Virol; 2012 Dec; 86(23):12494-502. PubMed ID: 23015699
[TBL] [Abstract][Full Text] [Related]
24. Could Changing the DNA Methylation Landscape Promote the Destruction of Epstein-Barr Virus-Associated Cancers?
Sinclair AJ
Front Cell Infect Microbiol; 2021; 11():695093. PubMed ID: 34123880
[TBL] [Abstract][Full Text] [Related]
25. Epigenetics of Epstein Barr virus - A review.
Shareena G; Kumar D
Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166838. PubMed ID: 37544529
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of latent Epstein-Barr virus promoters.
Takacs M; Banati F; Koroknai A; Segesdi J; Salamon D; Wolf H; Niller HH; Minarovits J
Biochim Biophys Acta; 2010; 1799(3-4):228-35. PubMed ID: 19853674
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.
Murata T; Kondo Y; Sugimoto A; Kawashima D; Saito S; Isomura H; Kanda T; Tsurumi T
J Virol; 2012 May; 86(9):4752-61. PubMed ID: 22357272
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic induction of cellular high CpG methylation by Epstein-Barr virus in malignant epithelial cells.
Li L; Zhang Y; Guo BB; Chan FK; Tao Q
Chin J Cancer; 2014 Dec; 33(12):604-8. PubMed ID: 25322866
[TBL] [Abstract][Full Text] [Related]
30. Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.
Schaefer BC; Strominger JL; Speck SH
Mol Cell Biol; 1997 Jan; 17(1):364-77. PubMed ID: 8972217
[TBL] [Abstract][Full Text] [Related]
31. Role of epigenetics in EBV regulation and pathogenesis.
Niller HH; Tarnai Z; Decsi G; Zsedényi A; Bánáti F; Minarovits J
Future Microbiol; 2014; 9(6):747-56. PubMed ID: 25046522
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic silencing of tumor suppressor genes during in vitro Epstein-Barr virus infection.
Saha A; Jha HC; Upadhyay SK; Robertson ES
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5199-207. PubMed ID: 26324942
[TBL] [Abstract][Full Text] [Related]
33. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of the truncated basic hair keratin 1(hHb1-DeltaN) in carcinoma cells by Epstein-Barr virus (EBV).
Nishikawa J; Kiss C; Imai S; Takada K; Okita K; Klein G; Szekely L
Int J Cancer; 2003 Nov; 107(4):597-602. PubMed ID: 14520698
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic control of viral life-cycle by a DNA-methylation dependent transcription factor.
Flower K; Thomas D; Heather J; Ramasubramanyan S; Jones S; Sinclair AJ
PLoS One; 2011; 6(10):e25922. PubMed ID: 22022468
[TBL] [Abstract][Full Text] [Related]
36. Modulation of Cellular CpG DNA Methylation by Kaposi's Sarcoma-Associated Herpesvirus.
Journo G; Tushinsky C; Shterngas A; Avital N; Eran Y; Karpuj MV; Frenkel-Morgenstern M; Shamay M
J Virol; 2018 Aug; 92(16):. PubMed ID: 29899086
[TBL] [Abstract][Full Text] [Related]
37. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783
[TBL] [Abstract][Full Text] [Related]
38. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
[TBL] [Abstract][Full Text] [Related]
39. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
[TBL] [Abstract][Full Text] [Related]
40. The lytic phase of epstein-barr virus requires a viral genome with 5-methylcytosine residues in CpG sites.
Kalla M; Göbel C; Hammerschmidt W
J Virol; 2012 Jan; 86(1):447-58. PubMed ID: 22031942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]